Aurinia Pharmaceuticals AUPH
NASDAQ AUPH
$16.08 -0.04 (-0.25%)
As of: Sep 4, 2026 · 3:59 PM EDT

Aurinia Pharmaceuticals (AUPH) Prepaid Assets (2016 - 2026)

Aurinia Pharmaceuticals' (AUPH) quarterly Prepaid Assets came in at $4.1 million in Q1 2026, down 25.58% YoY from $5.5 million in Q1 2025, and down 28.32% on a QoQ basis from $5.7 million in Q4 2025.

Analysis

Aurinia Pharmaceuticals (AUPH) Prepaid Assets (2016 - 2026) Analysis & Trends

Aurinia Pharmaceuticals (AUPH) has 11 years of Prepaid Assets data on file, last reported at $4.1 million in Q1 2026.

  • Quarterly Prepaid Assets fell 25.58% year-over-year to $4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.1 million (down 25.58% YoY) and the FY2025 annual result came in at $5.7 million, up 408.95% from the prior year.
  • Prepaid Assets declined to $4.1 million in Q1 2026, from $5.7 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $17.4 million in Q2 2022 to a low of $301000.0 in Q3 2025.
  • A 5-year average of $5.6 million and a median of $4.1 million in 2026 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2024 — Prepaid Assets soared 739.82% — and 2025, when it tumbled 97.82%.
  • Tracing AUPH's Prepaid Assets over 5 years: stood at $1.3 million in 2022, then retreated by 22.71% to $1.0 million in 2023, then climbed by 9.51% to $1.1 million in 2024, then soared by 408.95% to $5.7 million in 2025, then fell by 28.32% to $4.1 million in 2026.
  • The last three Prepaid Assets figures came in at $4.1 million (Q1 2026), $5.7 million (Q4 2025), and $301000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Aurinia Pharmaceuticals 2.10 Bn 1.66 Bn 76.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.53 Mn
Mar 31, 2026 4.12 Mn
Dec 31, 2025 5.75 Mn
Sep 30, 2025 11.11 Mn
Jun 30, 2025 6.58 Mn
Mar 31, 2025 5.54 Mn
Dec 31, 2024 11.22 Mn
Sep 30, 2024 13.82 Mn
Jun 30, 2024 7.84 Mn
Mar 31, 2024 7.65 Mn
Dec 31, 2023 9.49 Mn
Sep 30, 2023 16.16 Mn
Jun 30, 2023 11.33 Mn
Mar 31, 2023 10.10 Mn
Dec 31, 2022 13.58 Mn
Sep 30, 2022 12.16 Mn
Jun 30, 2022 17.42 Mn
Mar 31, 2022 12.20 Mn
Dec 31, 2021 11.71 Mn
Sep 30, 2021 13.71 Mn